336 related articles for article (PubMed ID: 25848843)
41. Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens.
Xu X; Golden JA; Dolganov G; Jones KD; Donnelly S; Weaver T; Caughey GH
J Heart Lung Transplant; 2005 Aug; 24(8):1055-66. PubMed ID: 16102441
[TBL] [Abstract][Full Text] [Related]
42. Multidrug resistance in lung allograft recipients: possible correlation with the development of acute and chronic rejection.
Yousem SA; Sartori D; Sonmez-Alpan E
J Heart Lung Transplant; 1993; 12(1 Pt 1):20-6. PubMed ID: 8095160
[TBL] [Abstract][Full Text] [Related]
43. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans?
Yousem SA; Dauber JA; Keenan R; Paradis IL; Zeevi A; Griffith BP
Transplantation; 1991 Aug; 52(2):306-9. PubMed ID: 1871804
[TBL] [Abstract][Full Text] [Related]
44. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
45. Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model.
Nusair S; Or R; Junadi S; Amir G; Breuer R
Chest; 2005 Dec; 128(6):4024-9. PubMed ID: 16354876
[TBL] [Abstract][Full Text] [Related]
46. Early infections and bronchiolitis obliterans-organizing pneumonia in single lung transplant recipients.
Barberis M; Bauer D; Harari S; Belloni PA; Masini T; Baisi A
J Heart Lung Transplant; 1992; 11(5):1012-4. PubMed ID: 1420231
[No Abstract] [Full Text] [Related]
47. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
Ross DJ; Marchevsky A; Kramer M; Kass RM
J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
[TBL] [Abstract][Full Text] [Related]
48. Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis.
Babu AN; Murakawa T; Thurman JM; Miller EJ; Henson PM; Zamora MR; Voelkel NF; Nicolls MR
J Clin Invest; 2007 Dec; 117(12):3774-85. PubMed ID: 18060031
[TBL] [Abstract][Full Text] [Related]
49. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
Jaramillo A; Fernández FG; Kuo EY; Trulock EP; Patterson GA; Mohanakumar T
Pediatr Transplant; 2005 Feb; 9(1):84-93. PubMed ID: 15667618
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation.
Chamberlain D; Maurer J; Chaparro C; Idolor L
J Heart Lung Transplant; 1994; 13(6):963-71. PubMed ID: 7865530
[TBL] [Abstract][Full Text] [Related]
51. [Bronchiolitis obliterans after lung transplantation].
Fournier M; Groussard O; Sleiman C; Mal H; Darne C; Pariente R
Presse Med; 1992 May 2-9; 21(17):816-20. PubMed ID: 1535143
[TBL] [Abstract][Full Text] [Related]
52. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
53. [Graft immunity in lung transplantation].
Mornex JF
Rev Mal Respir; 2003 Apr; 20(2 Pt 1):257-66. PubMed ID: 12844023
[TBL] [Abstract][Full Text] [Related]
54. Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents.
Cova E; Inghilleri S; Pandolfi L; Morosini M; Magni S; Colombo M; Piloni D; Finetti C; Ceccarelli G; Benedetti L; Cusella MG; Agozzino M; Corsi F; Allevi R; Mrakic-Sposta S; Moretti S; De Gregori S; Prosperi D; Meloni F
Nanotoxicology; 2017 May; 11(4):534-545. PubMed ID: 28415888
[TBL] [Abstract][Full Text] [Related]
55. [Bronchiolitis obliterans syndrome in lung transplant recipients].
Antus B; Fillinger J; Csiszér E; Czebe K; Horváth I
Orv Hetil; 2005 May; 146(19):953-8. PubMed ID: 15969307
[TBL] [Abstract][Full Text] [Related]
56. Dendritic cells and macrophages in lung allografts: A role in chronic rejection?
Leonard CT; Soccal PM; Singer L; Berry GJ; Theodore J; Holt PG; Doyle RL; Rosen GD
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1349-54. PubMed ID: 10764333
[TBL] [Abstract][Full Text] [Related]
57. Chronic rejection pathology after orthotopic lung transplantation in mice: the development of a murine BOS model and its drawbacks.
De Vleeschauwer S; Jungraithmayr W; Wauters S; Willems S; Rinaldi M; Vaneylen A; Verleden S; Willems-Widyastuti A; Bracke K; Brusselle G; Verbeken E; Van Raemdonck D; Verleden G; Vanaudenaerde B
PLoS One; 2012; 7(1):e29802. PubMed ID: 22238655
[TBL] [Abstract][Full Text] [Related]
58. Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling.
Sato M; Keshavjee S
Semin Thorac Cardiovasc Surg; 2008; 20(2):173-82. PubMed ID: 18707652
[TBL] [Abstract][Full Text] [Related]
59. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.
Takenaka M; Subramanian V; Tiriveedhi V; Phelan D; Hachem R; Trulock E; Gelman AE; Patterson GA; Hoshinaga K; Mohanakumar T
J Heart Lung Transplant; 2012 Nov; 31(11):1214-22. PubMed ID: 22980951
[TBL] [Abstract][Full Text] [Related]
60. Development of obliterative bronchiolitis after allogeneic rat lung transplantation: implication of acute rejection and the time point of treatment.
Hirt SW; You XM; Möller F; Boeke K; Starke M; Spranger U; Wottge HU
J Heart Lung Transplant; 1999 Jun; 18(6):542-8. PubMed ID: 10395352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
